Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Relay Therapeutics (RLAY) Other Non-Current Assets (2020 - 2025)

Relay Therapeutics (RLAY) has disclosed Other Non-Current Assets for 6 consecutive years, with $1.3 million as the latest value for Q4 2025.

  • Quarterly Other Non-Current Assets fell 36.95% to $1.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.3 million through Dec 2025, down 36.95% year-over-year, with the annual reading at $1.3 million for FY2025, 36.95% down from the prior year.
  • Other Non-Current Assets for Q4 2025 was $1.3 million at Relay Therapeutics, down from $2.3 million in the prior quarter.
  • The five-year high for Other Non-Current Assets was $2.7 million in Q2 2023, with the low at $878000.0 in Q1 2021.
  • Average Other Non-Current Assets over 5 years is $2.4 million, with a median of $2.6 million recorded in 2021.
  • The sharpest move saw Other Non-Current Assets soared 11618.18% in 2021, then crashed 36.95% in 2025.
  • Over 5 years, Other Non-Current Assets stood at $2.6 million in 2021, then changed by 0.0% to $2.6 million in 2022, then grew by 5.0% to $2.7 million in 2023, then fell by 21.72% to $2.1 million in 2024, then plummeted by 36.95% to $1.3 million in 2025.
  • According to Business Quant data, Other Non-Current Assets over the past three periods came in at $1.3 million, $2.3 million, and $2.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.